Sogen Data · Datasets · 数据专题

肉瘤复发轴数据集锦

单细胞 · bulk 转录组

本专题承自 Sogen Data 数据整理体系,逐条人工复核,附研究设计、样本量、平台与 GEO/PubMed 直达链接。

人源单细胞

Human · Single-cell

  1. 01 GSE288065 对MYOD1 L122R突变的横纹肌肉瘤患者来源样本(n=7)进行单核RNA测序,比较原发与复发/转移样本的转录异质性。 人源 · 7 例 · GPL18573 · 2026/01/22

    设计对MYOD1 L122R突变的横纹肌肉瘤患者来源样本(n=7)进行单核RNA测序,比较原发与复发/转移样本的转录异质性。

    摘要We perform single nuclei transcriptomics (snRNA-seq) analysis of patient-derived tumor samples to define the dynamic myogenic cell states and intratumoral transcriptional heterogeneity of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcoma.

人源bulk 转录组

Human · Bulk RNA-seq

  1. 01 GSE30929 对140例人类脂肉瘤样本进行Affymetrix U133A芯片表达分析,样本随机分为训练集(n=95)和测试集(n=45),通过监督主成分分析法开发多基因预测模型以评估远处无复发生存率(DRFS)。检测结果显示,低风险评分患者3年DRFS为83%,高风险评分患者为45%(P=0.001)。风险评分与DRFS的协和概率为0.732。预测模型中包含与脂肪生成、DNA复制、有丝分裂及纺锤体组装检查点调控相关的基因。TOP2A、PTK7和CHEK1基因在所有五种脂肉瘤亚型及脂肉瘤细胞系中均被过表达,其在脂肉瘤细胞系中的敲低实验显示可抑制增殖和侵袭并促进凋亡。 人源 · 140 例 · GPL96 · 2011/09/02

    设计对140例人类脂肉瘤样本进行Affymetrix U133A芯片表达分析,样本随机分为训练集(n=95)和测试集(n=45),通过监督主成分分析法开发多基因预测模型以评估远处无复发生存率(DRFS)。检测结果显示,低风险评分患者3年DRFS为83%,高风险评分患者为45%(P=0.001)。风险评分与DRFS的协和概率为0.732。预测模型中包含与脂肪生成、DNA复制、有丝分裂及纺锤体组装检查点调控相关的基因。TOP2A、PTK7和CHEK1基因在所有五种脂肉瘤亚型及脂肉瘤细胞系中均被过表达,其在脂肉瘤细胞系中的敲低实验显示可抑制增殖和侵袭并促进凋亡。

    摘要Liposarcoma is the most common soft tissue sarcoma, accounting for about 20% of cases. Liposarcoma is classified into 5 histologic subtypes that fall into 3 biological groups characterized by specific genetic alterations. To identify genes that contribute to liposarcomagenesis and to better predict outcome for patients with the disease, we undertook expression profiling of liposarcoma. U133A expression profiling was performed on 140 primary liposarcoma samples, which were randomly split into training set (n=95) and test set (n=45). A multi-gene predictor for distant recurrence-free survival (DRFS) was developed using the supervised principal component method. Expression levels of the 588 genes in the predictor were used to calculate a risk score for each patient. In validation of the predictor in the test set, patients with low risk score had a 3-year DRFS of 83% vs. 45% for high risk score patients (P=0.001). The hazard ratio for high vs. low score, adjusted for histologic subtype, was 4.42 (95% confidence interval 1.26-15.55; P=0.021). The concordance probability for risk score was 0.732. Genes related to adipogenesis, DNA replication, mitosis, and spindle assembly checkpoint control were all highly represented in the multi-gene predictor. Three genes from the predictor, TOP2A, PTK7, and CHEK1, were found to be overexpressed in liposarcoma samples of all five subtypes and in liposarcoma cell lines. Knockdown of these genes in liposarcoma cell lines reduced proliferation and invasiveness and increased apoptosis. Thus, genes identified from this predictor appear to have roles in liposarcomagenesis and have promise as therapeutic targets. In addition, the multi-gene predictor will improve risk stratification for individual patients with liposarcoma.

  2. 02 GSE17674 对44例Ewing肉瘤家族肿瘤患者样本、11例Ewing肉瘤家族肿瘤细胞系样本和18例正常肌肉组织样本进行基因表达分析,选取238个炎症相关基因,通过t检验分析基因差异表达,并基于基因表达进行生存分析。研究对象为Ewing肉瘤家族肿瘤患者,检测方式为基因表达分析,主要比较肿瘤患者与细胞系样本、肿瘤患者与正常肌肉组织样本的炎症基因表达差异。 人源 · 62 例 · GPL570 · 2011/12/01

    设计对44例Ewing肉瘤家族肿瘤患者样本、11例Ewing肉瘤家族肿瘤细胞系样本和18例正常肌肉组织样本进行基因表达分析,选取238个炎症相关基因,通过t检验分析基因差异表达,并基于基因表达进行生存分析。研究对象为Ewing肉瘤家族肿瘤患者,检测方式为基因表达分析,主要比较肿瘤患者与细胞系样本、肿瘤患者与正常肌肉组织样本的炎症基因表达差异。

    摘要Purpose: Unlike in most adult-onset cancers, an association between typical paediatric neoplasms and inflammatory triggers is rare. We studied whether immune system related genes are activated and have prognostic significance in Ewing sarcoma family of tumours (ESFT). Experimental design: Data-analysis was performed on gene expression profiles of 44 ESFT patient, 11 ESFT cell line, and 18 normal muscle tissue samples. 238 inflammation related genes were selected based on literature and a macrophage gene expression signature was derived from SymAtlas. Differential expression of the genes was analysed by t-test and survival analysis was performed according to gene expression. Results: Inflammatory genes are activated in ESFT patient samples, as 38 of 238 (16%) inflammatory genes were significantly upregulated (p<0.001) when compared to ESFT cell lines. This inflammatory gene activation was characterized by significant enrichment of macrophage related gene expression with 58 of 299 (19%) of these genes being upregulated (p<0.001). By combining expression data from ESFT patients, cell lines and muscle tissue samples we were able to identify a total of 32 presumptive inflammatory genes that characterize and distinguish tumour site in vivo from surrounding normal tissues. High expression of C5 correlated with better event free (p=0.01) and overall survival (p=0.004) in dose dependent manner. C5 and its receptor C5aR1 expression was verified at protein level by immunohistochemistry on tumor tissue microarray. Also, high expression of JAK1 correlated with favourable overall survival (p=0.04) and high expression of IL8, derived presumably from infiltrating immune cells, resulted in poor overall survival in Ewing sarcoma (p=0.04). Conclusions: Immune system related gene activation is observed in ESFT patient samples and several prognostically significant inflammatory genes (C5, JAK1 and IL8) for ESFT were identified.

  3. 03 GSE54187 对54例软组织肉瘤患者的64份冷冻肿瘤标本进行基因表达分析,其中15例为未发生转移/复发的原发肿瘤(SynSa1组),21例为未治疗但发生转移/复发的原发肿瘤(SynSa2组),21例为同步转移/复发肿瘤(SynSa3组),采用Agilent One-Color技术检测基因表达差异。 人源 · 57 例 · GPL13497 · 2014/07/31

    设计对54例软组织肉瘤患者的64份冷冻肿瘤标本进行基因表达分析,其中15例为未发生转移/复发的原发肿瘤(SynSa1组),21例为未治疗但发生转移/复发的原发肿瘤(SynSa2组),21例为同步转移/复发肿瘤(SynSa3组),采用Agilent One-Color技术检测基因表达差异。

    摘要Synovial sarcoma (SynSa) is an aggressive mesenchymal tumor, comprising approximately 10% of all soft tissue sarcomas. Over half of SynSa patients develop metastasis or local recurrence, but the underlying molecular mechanisms of the aggressive clinical behavior remain poorly characterized. Sixty four frozen tumor specimens from 54 SynSa patients were subjected to array comparative genomic hybridization (aCGH) and gene expression profiling. The examined set of tumor specimens included 16 primary tumors from untreated patients who did not develop metastasis/local recurrence (SynSa1 group), 26 primary tumors from untreated patients who developed metastases or local recurrence during follow-up (SynSa2 group), and 22 metachronous metastatic/recurrent SynSa tumors (SynSa3 group). AURKA and KIF18A, which play important roles in various mitotic events, were the two most up-regulated genes in SynSa2 and SynSa3 groups compared to the SynSa1 group. Expression profiles of SynSa2 and SynSa3 tumors did not show any significant differences. Analysis of genomic index (GI) based on aCGH profiles demonstrated that the SynSa1 group consisted of tumors with significantly less complex genomes compared to SynSa2 and SynSa3 groups. There was no significant difference in genome complexity between SynSa2 and SynSa3 tumors. Primary SynSa tumors from patients who develop metastases or local recurrence share common molecular features with metastatic/recurrent tumors. Presented data suggest that the aggressive clinical SynSa behavior is determined early in tumorigenesis and might be related to impaired regulation of mitotic mechanisms. Introduction: Synovial sarcoma (SynSa) is an aggressive mesenchymal tumor, comprising approximately 10% of all soft tissue sarcomas. Over half of SynSa patients develop metastasis or local recurrence, but the underlying molecular mechanisms of the aggressive clinical behavior remain poorly characterized. Materials and methods: Sixty four frozen tumor specimens from 54 SynSa patients were subjected to array comparative genomic hybridization (aCGH) and gene expression profiling. The examined set of tumor specimens included 16 primary tumors from untreated patients who did not develop metastasis/local recurrence (SynSa1 group), 26 primary tumors from untreated patients who developed metastases or local recurrence during follow-up (SynSa2 group), and 22 metachronous metastatic/recurrent SynSa tumors (SynSa3 group). Results: AURKA and KIF18A, which play important roles in various mitotic events, were the two most up-regulated genes in SynSa2 and SynSa3 groups compared to the SynSa1 group. Expression profiles of SynSa2 and SynSa3 tumors did not show any significant differences. Analysis of genomic index (GI) based on aCGH profiles demonstrated that the SynSa1 group consisted of tumors with significantly less complex genomes compared to SynSa2 and SynSa3 groups. There was no significant difference in genome complexity between SynSa2 and SynSa3 tumors. Conclusions: Primary SynSa tumors from patients who develop metastases or local recurrence share common molecular features with metastatic/recurrent tumors. Presented data suggest that the aggressive clinical SynSa behavior is determined early in tumorigenesis and might be related to impaired regulation of mitotic mechanisms.

  4. 04 GSE85383 对人类子宫来源的低级别和高级别子宫内膜间质肉瘤、高度恶性未分化子宫肉瘤及子宫平滑肌肉瘤样本进行总RNA提取,采用Agilent One-Color技术检测基因表达,比较不同肿瘤类型的转录组特征。 人源 · 25 例 · GPL22303 · 2017/08/01

    设计对人类子宫来源的低级别和高级别子宫内膜间质肉瘤、高度恶性未分化子宫肉瘤及子宫平滑肌肉瘤样本进行总RNA提取,采用Agilent One-Color技术检测基因表达,比较不同肿瘤类型的转录组特征。

    摘要Sarcomas originating from the endometrial stroma include low- and high-grade endometrial stromal sarcomas (ESS) that are associated with specific translocations, and highly malignant undifferentiated uterine sarcomas (UUS). UUS is considered a poorly defined group of tumors and is often seen as a “diagnosis of exclusion” after ESS and leiomyosarcoma (LMS) have been ruled out. Through gene expression profiling, we show that UUS form a well-defined group of tumors with a unique genetic profile distinct from LMS and both subtypes of ESS.

  5. 05 GSE202978 对滑膜肉瘤患者治疗前及治疗后进展期的肿瘤组织进行基因表达分析,比较治疗前后样本的差异。使用NanoString nCounter系统分析总RNA,同时运行PanCancer Immune Profiling Panel和PanCancer Pathway Panel试剂盒。样本来自10名治疗前患者(13个样本,其中3名患者有2个重复样本)和5名进展期患者,共23个样本。排除5个样本因收集时间或分析重点。每个样本使用5张4微米切片进行宏解剖和RNA提取,RNA质量通过Agilent RNA Pico芯片评估。 人源 · 23 例 · GPL32232 · 2022/05/16

    设计对滑膜肉瘤患者治疗前及治疗后进展期的肿瘤组织进行基因表达分析,比较治疗前后样本的差异。使用NanoString nCounter系统分析总RNA,同时运行PanCancer Immune Profiling Panel和PanCancer Pathway Panel试剂盒。样本来自10名治疗前患者(13个样本,其中3名患者有2个重复样本)和5名进展期患者,共23个样本。排除5个样本因收集时间或分析重点。每个样本使用5张4微米切片进行宏解剖和RNA提取,RNA质量通过Agilent RNA Pico芯片评估。

    摘要Autologous T cells transduced to express a high affinity T-cell receptor specific to NY-ESO-1 (letetresgene autoleucel, lete-cel) show promise in the treatment of metastatic synovial sarcoma, with 50% overall response rate. Biomarkers predictive of response and resistance remain to be better defined. In 45 synovial sarcoma patients, we analyzed the association of response to lete-cel (NCT01343043) with tumor gene expression. Analysis of tumor samples post-treatment illustrated lete-cel infiltration and decreased expression of macrophage genes, suggesting remodeling of the tumor microenvironment.

  6. 06 GSE203215 对皮肤血管肉瘤患者的FFPE活检样本进行RNA测序,比较原发性病变与复发性病变的基因表达差异。 人源 · 15 例 · GPL24014 · 2022/12/03

    设计对皮肤血管肉瘤患者的FFPE活检样本进行RNA测序,比较原发性病变与复发性病变的基因表达差异。

    摘要To investigate tumor immune microenvironment in cutaneous angiosarcoma, we performed comprehensive RNA sequencing using Next-generation sequencer

  7. 07 GSE14325 对10例NOS软组织肉瘤样本进行基因表达分析,采用微阵列技术比较其基因表达差异,以关联组织学特征和临床过程。 人源 · 10 例 · GPL571 · 2011/01/03

    设计对10例NOS软组织肉瘤样本进行基因表达分析,采用微阵列技术比较其基因表达差异,以关联组织学特征和临床过程。

    摘要This study was performed to identify gene expression differences in not otherwise specified soft tissue sarcomas (NOS, malignant fibrous histiocytomas) and correlate them to histological findings and the clinical course. RNA was isolated and differential gene expression was analysed by the microarray technique. We used microarrays to detail the global gene expression differences between primary soft tissue sarcoma samples, harvested intraoperatively. Keywords: response to chemotherapeutic agent

  8. 08 GSE184199 将四例去分化脂肪肉瘤(DDL)组织样本与四例根据性别、年龄和复发状态匹配的良性分化脂肪肉瘤(WDL)组织样本进行高通量RNA测序,采集总RNA并采用Illumina Hiseq平台深度测序生成RNA-seq数据,比较DDL与对应WDL样本的基因表达差异。 人源 · 8 例 · GPL20301 · 2021/09/17

    设计将四例去分化脂肪肉瘤(DDL)组织样本与四例根据性别、年龄和复发状态匹配的良性分化脂肪肉瘤(WDL)组织样本进行高通量RNA测序,采集总RNA并采用Illumina Hiseq平台深度测序生成RNA-seq数据,比较DDL与对应WDL样本的基因表达差异。

    摘要Dedifferentiated liposarcoma (DDL) has the same cellular and molecular genetics features as well-differentiated liposarcoma (WDL), and there is still no ideal biomarker for the prediction of DDL patient prognosis in clinical practice. In order to explore the genes that cause WDL to obtain local invasion and distant metastasis capacities and transform it into DDL, The four DDL tissue specimens in this study were matched with four WDL tissue specimens according to baseline characteristics, such as gender, age, and recurrence, before high-throughput sequencing was conducted. Then total RNAs were subjected to RNA isolation and RNA-seq analyses were generated by deep sequencing using Illumina Hiseq.

  9. 09 GSE324018 对同一名患者来源的原发股部软组织肿瘤与复发股部皮下肿瘤样本进行bulk RNA测序,比较两者转录组差异。采用酸胍基乙酰胺硫氰酸盐-酚-氯仿(AGPC)法提取总RNA,使用cDNA文库策略进行RNA-Seq测序,测序数据用于质量评估、比对/定量及融合转录本筛查。 人源 · 2 例 · GPL34284 · 2026/04/03

    设计对同一名患者来源的原发股部软组织肿瘤与复发股部皮下肿瘤样本进行bulk RNA测序,比较两者转录组差异。采用酸胍基乙酰胺硫氰酸盐-酚-氯仿(AGPC)法提取总RNA,使用cDNA文库策略进行RNA-Seq测序,测序数据用于质量评估、比对/定量及融合转录本筛查。

    摘要Bulk RNA sequencing was performed on two human synovial sarcoma specimens from a single patient: a primary thigh soft-tissue tumor and a recurrent subcutaneous thigh lesion.

微信二维码

课题合作 · 扫码加微信

bioinformaticsboy